We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genomic Signal Processing May Provide Insights into Cancer Treatment

By LabMedica International staff writers
Posted on 22 Dec 2010
A scientist is applying some of the tools of his specialty to try to prod genetic behavior in ways that may cure disease in the near future.

Dr. More...
Dan Schonfeld, professor of electrical and computer engineering at the University of Illinois at Chicago (IL, USA), and a leading expert in image and video analysis, is studying gene expression and interactions in ways that are analogous to the workings of electrical or computer networks. He is project director and lead investigator of a four-year, US$1.2 million National Institutes of Health (Bethesda, MD, USA) grant.

"The idea is that DNA gives expression to proteins, and the amount and level of proteins dictates the state of the organism,” Dr. Schonfeld said.”If the expression level of one DNA goes up, it might reduce the expression level of another. There is this symbiotic relation between the genes in a network and the expression level of each of the proteins depends on one another.”

Dr. Schonfeld envisions this dynamic behavior leading to production of either good or bad proteins. He envisions that using the tools of mathematics and engineering will lead to a way to control this protein production. To achieve this, he and his colleagues model gene regulatory networks as a Markov chain--a statistical modeling tool frequently used in software development. They monitor the network over time and make slight changes or perturbations that may provide a level of control. "We've actually formed a new subarea of inverse perturbation theory where we say we know where we want to go, what is the smallest change in the network that we need to impose in order to guarantee that wherever we are, we're going to end up where we'd like to be,” he said.

Dr. Schonfeld reported that his objective is to take the results of mathematic analysis, convert them into a protocol for making small changes by putting specific chemicals into the cell resulting in a small change in the network, and then monitor its behavior over time to see whether it generates results predicted from the mathematic analysis.

Their hypothetic model will be tested on melanoma cells using RNA interference and plasmid molecules designed to regulate the expression levels of specific genes in a melanoma network. "We need to perturb and affect the influence of one gene on the other in order to move it in a better direction,” he said. "The successful outcome of the proposed approach to the treatment of malignant melanoma cells could serve as a foundation for development of intervention strategies in other cancer networks.”

Dr. Schonfeld noted that an interdisciplinary approach is "essential to an effective plan for developing novel treatment and clinical decision making in cancer research.”

Related Links:

University of Illinois at Chicago



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.